<DOC>
	<DOCNO>NCT00061997</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . Inositol may effective preventing development lung cancer patient bronchial epithelial dysplasia . PURPOSE : This phase I trial study side effect best dose inositol prevent lung cancer current former smoker bronchial epithelial dysplasia .</brief_summary>
	<brief_title>Inositol Preventing Lung Cancer Patients With Bronchial Epithelial Dysplasia Who Are Current Former Smokers</brief_title>
	<detailed_description>OBJECTIVES : - Determine safety inositol prevention lung cancer patient bronchial epithelial dysplasia current former smoker . - Determine potential efficacy drug regression exist dysplastic lesion prevention appearance new dysplastic lesion patient . - Determine whether intake drug facilitate smoking cessation patient current smoker . OUTLINE : This dose-escalation study . Patients receive oral inositol twice daily . Treatment continue 1 3 month absence disease progression unacceptable toxicity . Cohorts 3-12 patient receive escalate dos inositol maximum tolerate dose ( MTD ) determine . The MTD define dose precede 3 12 patient experience dose-limiting toxicity . Once MTD determine , 10 patient treated inositol twice daily MTD 3 month absence disease progression unacceptable toxicity . Patients follow 1 month . PROJECTED ACCRUAL : A total 3-28 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis persistent bronchial dysplasia despite regular twicedaily treatment inhale budesonide 6 12 month protocol BCCACIC9837 Current former smoker smoke least 30 pack year Sputum cell show AIC atypia computerassisted image analysis At least 2 abnormal site fluorescence bronchoscopy ( red/green ratio least 0.45 ) suspicious bronchial dysplasia At least 1 site confirm bronchial biopsy Solitary dysplastic lesion allow provide diameter great 1.5 mm No invasive cancer bronchoscopy abnormal lowdose spiral CT scan suspicious lung cancer PATIENT CHARACTERISTICS : Age 40 74 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Hematologic function normal No bleeding disorder Hepatic Liver function normal Liver enzymes great upper limit normal Renal Renal function normal Cardiovascular No unstable angina No congestive heart failure Pulmonary No acute chronic respiratory failure No acute bronchitis pneumonia within past month Other Fasting glucose less 144 mg/dL Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Willing bronchoscopy No schizophrenia No bipolar disorder No diabetes No known reaction topical xylocaine No medical condition would jeopardize patient safety study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy Surgery No prior surgery lung cancer Other No concurrent lithium</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>precancerous condition</keyword>
</DOC>